DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 78 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2014. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,923,000 | -56.4% | 1,246,397 | +15.9% | 0.00% | -50.0% |
| Q3 2016 | $11,280,000 | -23.6% | 1,075,267 | +6.1% | 0.00% | -33.3% |
| Q2 2016 | $14,772,000 | -19.2% | 1,013,173 | +6.6% | 0.00% | -25.0% |
| Q1 2016 | $18,293,000 | -23.9% | 950,782 | -4.5% | 0.00% | -33.3% |
| Q4 2015 | $24,047,000 | +2.1% | 995,307 | +3.7% | 0.01% | 0.0% |
| Q3 2015 | $23,545,000 | +29.7% | 959,461 | +23.8% | 0.01% | +50.0% |
| Q2 2015 | $18,152,000 | +3.5% | 774,887 | -0.9% | 0.00% | 0.0% |
| Q1 2015 | $17,532,000 | +43.6% | 781,629 | +8.0% | 0.00% | +33.3% |
| Q4 2014 | $12,205,000 | – | 723,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
| DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
| Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
| PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
| Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
| Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
| Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
| Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |